Zobrazeno 1 - 10
of 190
pro vyhledávání: '"S V Rajkumar"'
Autor:
I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, S. Hayman, T. Kourelis, R. Warsame, Y. Hwa, A. Fonder, M. Hobbs, E. Muchtar, N. Leung, P. Kapoor, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. Rajkumar, M. A. Gertz, A. Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/744df0ab94de46598b60fe543ab0afab
Autor:
I. Vaxman, J. Abeykoon, A. Dispenzieri, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder, M. Hobbs, C. Reeder, T. Sher, S. Hayman, T. Kourelis, R. Warsame, E. Muchtar, N. Leung, R. Go, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. Rajkumar, McCullough Kristen, P. Kapoor, M. A. Gertz
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Abstract Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomized clinical trials. We report the outcomes of 3
Externí odkaz:
https://doaj.org/article/052538cf28fe46f1b641764536e6bd67
Autor:
A. Visram, C. Soof, S. V. Rajkumar, S. K. Kumar, S. Bujarski, T. M. Spektor, R. A. Kyle, J. R. Berenson, A. Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-7 (2021)
Abstract Soluble BCMA (sBCMA) levels are elevated in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). However, the association between sBCMA levels and prognosis in MGUS and SMM has not been studied. We
Externí odkaz:
https://doaj.org/article/968f228ca2df4749a131b3c805cfafd2
Autor:
S. Usmani, A. Hoering, S. Ailawadhi, R. Sexton, B. Lipe, J. Valent, M. Rosenzweig, J. Zonder, M. Dhodapkar, N. Callander, T. Zimmerman, P. Voorhees, B. Durie, S. V. Rajkumar, P. Richardson, R. Orlowski
Publikováno v:
HemaSphere, Vol 6, Pp 855-856 (2022)
Externí odkaz:
https://doaj.org/article/c2f21220f24849ceb2ed8389d8158765
Autor:
Gita Thanarajasingam, Asher Chanan-Khan, Prashant Kapoor, Angela Dispenzieri, Ronald S. Go, Wilson I. Gonsalves, Eli Muchtar, Morie A. Gertz, Allison C. Rosenthal, Thomas M. Habermann, Rebecca L. King, Jithma P. Abeykoon, David J. Inwards, Francis K. Buadi, Patricia T. Greipp, Vivek Roy, Sikander Ailawadhi, Robert A. Kyle, Grzegorz S. Nowakowski, Craig B. Reeder, David Dingli, Carrie A. Thompson, Jonas Paludo, Jeremy T. Larsen, Stephen M. Ansell, Thomas E. Witzig, Saurabh Zanwar, Rong He, S V Rajkumar, Taimur Sher, Shaji Kumar, Martha Q. Lacy
Publikováno v:
American Journal of Hematology. 96:945-953
Comparative data guiding initial therapy for Waldenstrom macroglobulinemia (WM), an infrequently encountered non-Hodgkin lymphoma, are sparse. We evaluated three commonly used frontline regimens: rituximab-bendamustine (R-Benda); dexamethasone, ritux
Autor:
Robert A. Kyle, Miriam Hobbs, A L Fonder, Eli Muchtar, Shaji Kumar, Prashant Kapoor, Iuliana Vaxman, Nelson Leung, Mustaqueem Siddiqui, S V Rajkumar, Ronald S. Go, D. Dingli, Martha Q. Lacy, Morie A. Gertz, Wilson I. Gonsalves, S.R. Hayman, Taxiarchis Kourelis, Yi Lisa Hwa, Rahma Warsame, Yi Lin, Francis K. Buadi, Martha Grogan, Angela Dispenzieri
Publikováno v:
Leukemia
Autor:
Bonnie K. Arendt, S V Rajkumar, Shaji Kumar, David L. Murray, Dirk R. Larson, Robert A. Kyle, Surendra Dasari, Angela Dispenzieri, Maria Willrcih, Taxiarchis Kourelis
Publikováno v:
Leukemia
Our group previously demonstrated that M-protein light chain (LC) glycosylation can be detected on routine MASS-FIX testing. Glycosylation is increased in patients with immunoglobulin light chain amyloidosis (AL) and rarely changes over the course of
Autor:
James R. Berenson, Camilia Soof, Shaji Kumar, Angela Dispenzieri, S V Rajkumar, Alissa Visram, T. M. Spektor, Sean Bujarski, Robert A. Kyle
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-7 (2021)
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-7 (2021)
Soluble BCMA (sBCMA) levels are elevated in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). However, the association between sBCMA levels and prognosis in MGUS and SMM has not been studied. We retrospe
Autor:
Prashant Kapoor, David Dingli, Miriam Hobbs, John A. Lust, Steven Russell, Martha Q. Lacy, A L Fonder, Nelson Leung, Suzanne R. Hayman, Robert A. Kyle, Steven R. Zeldenrust, Morie A. Gertz, Ronald S. Go, Surbhi Sidana, Yi Lisa Hwa, S V Rajkumar, Francis K. Buadi, Angela Dispenzieri, Shaji Kumar, Nidhi Tandon, Wilson I. Gonsalves
Publikováno v:
Leukemia. 32:729-735
Hematologic response criteria in light chain (AL) amyloidosis require the difference in involved and uninvolved free light chains (dFLC) to be at least 5 mg/dl. We describe the clinical presentation and outcomes of newly diagnosed amyloidosis patient
Autor:
Joseph R. Mikhael, Yi Lin, Martha Q. Lacy, R Fonseca, Asher Chanan-Khan, Morie A. Gertz, Wilson I. Gonsalves, Shaji Kumar, Betsy LaPlant, David Dingli, Robert A. Kyle, Steven Russell, Francis K. Buadi, Suzanne R. Hayman, P L Bergsagel, Alexander Keith Stewart, Ronald S. Go, Nelson Leung, Taxiarchis Kourelis, Taimur Sher, Prashant Kapoor, Angela Dispenzieri, K M Laumann, Sikander Ailawadhi, John A. Lust, Vivek Roy, S V Rajkumar, Craig B. Reeder
Publikováno v:
Leukemia. 32:719-728
Despite therapeutic advances, multiple myeloma remains incurable, with limited options for patients with refractory disease. We conducted a large, multi-cohort clinical trial testing various doses and treatment schedules of pomalidomide and dexametha